Imagabalin has been investigated in Generalized Anxiety Disorder.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Imagabalin may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Imagabalin. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Imagabalin. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Imagabalin. |
| Hydrocodone | Imagabalin may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Imagabalin. |
| Magnesium sulfate | The therapeutic efficacy of Imagabalin can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Imagabalin may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Imagabalin may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Imagabalin. |
| Mirtazapine | Imagabalin may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Imagabalin. |
| Orphenadrine | Imagabalin may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Imagabalin may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Imagabalin. |
| Pramipexole | Imagabalin may increase the sedative activities of Pramipexole. |
| Ropinirole | Imagabalin may increase the sedative activities of Ropinirole. |
| Rotigotine | Imagabalin may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Imagabalin. |
| Sodium oxybate | Imagabalin may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Imagabalin may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Imagabalin. |
| Thalidomide | Imagabalin may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Imagabalin may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Yohimbine | The therapeutic efficacy of Imagabalin can be increased when used in combination with Yohimbine. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Imagabalin. |
| Ethanol | Imagabalin may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Imagabalin may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Imagabalin. |
| Fluvoxamine | The risk or severity of adverse effects can be increased when Imagabalin is combined with Fluvoxamine. |
| Citalopram | The risk or severity of adverse effects can be increased when Imagabalin is combined with Citalopram. |
| Duloxetine | The risk or severity of adverse effects can be increased when Imagabalin is combined with Duloxetine. |
| Trazodone | The risk or severity of adverse effects can be increased when Imagabalin is combined with Trazodone. |
| Paroxetine | The risk or severity of adverse effects can be increased when Imagabalin is combined with Paroxetine. |
| Sertraline | The risk or severity of adverse effects can be increased when Imagabalin is combined with Sertraline. |
| Sibutramine | The risk or severity of adverse effects can be increased when Imagabalin is combined with Sibutramine. |
| Nefazodone | The risk or severity of adverse effects can be increased when Imagabalin is combined with Nefazodone. |
| Escitalopram | The risk or severity of adverse effects can be increased when Imagabalin is combined with Escitalopram. |
| Zimelidine | The risk or severity of adverse effects can be increased when Imagabalin is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when Imagabalin is combined with Dapoxetine. |
| Milnacipran | The risk or severity of adverse effects can be increased when Imagabalin is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when Imagabalin is combined with Desvenlafaxine. |
| Seproxetine | The risk or severity of adverse effects can be increased when Imagabalin is combined with Seproxetine. |
| Indalpine | The risk or severity of adverse effects can be increased when Imagabalin is combined with Indalpine. |
| Ritanserin | The risk or severity of adverse effects can be increased when Imagabalin is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when Imagabalin is combined with Alaproclate. |
| Amitriptyline | The risk or severity of CNS depression can be increased when Amitriptyline is combined with Imagabalin. |
| Cyproheptadine | The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Imagabalin. |
| Imipramine | The risk or severity of CNS depression can be increased when Imipramine is combined with Imagabalin. |
| Nortriptyline | The risk or severity of CNS depression can be increased when Nortriptyline is combined with Imagabalin. |
| Amoxapine | The risk or severity of CNS depression can be increased when Amoxapine is combined with Imagabalin. |
| Propiomazine | The risk or severity of CNS depression can be increased when Propiomazine is combined with Imagabalin. |
| Maprotiline | The risk or severity of CNS depression can be increased when Maprotiline is combined with Imagabalin. |
| Doxepin | The risk or severity of CNS depression can be increased when Doxepin is combined with Imagabalin. |
| Desipramine | The risk or severity of CNS depression can be increased when Desipramine is combined with Imagabalin. |
| Pizotifen | The risk or severity of CNS depression can be increased when Pizotifen is combined with Imagabalin. |
| Dosulepin | The risk or severity of CNS depression can be increased when Dosulepin is combined with Imagabalin. |
| Zopiclone | The risk or severity of adverse effects can be increased when Imagabalin is combined with Zopiclone. |
| Botulinum toxin type B | The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Imagabalin. |
| Botulinum toxin type A | The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Imagabalin. |
| Tryptophan | The risk or severity of CNS depression can be increased when Tryptophan is combined with Imagabalin. |
| Baclofen | Baclofen may increase the central nervous system depressant (CNS depressant) activities of Imagabalin. |
| Lorazepam | The risk or severity of CNS depression can be increased when Lorazepam is combined with Imagabalin. |
| Ethchlorvynol | The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Imagabalin. |
| Succinylcholine | The risk or severity of CNS depression can be increased when Succinylcholine is combined with Imagabalin. |
| Reserpine | The risk or severity of CNS depression can be increased when Reserpine is combined with Imagabalin. |
| Eletriptan | The risk or severity of CNS depression can be increased when Eletriptan is combined with Imagabalin. |
| Enflurane | The risk or severity of CNS depression can be increased when Enflurane is combined with Imagabalin. |
| Temazepam | The risk or severity of CNS depression can be increased when Temazepam is combined with Imagabalin. |
| Reboxetine | The risk or severity of CNS depression can be increased when Reboxetine is combined with Imagabalin. |
| Butabarbital | The risk or severity of CNS depression can be increased when Butabarbital is combined with Imagabalin. |
| Butalbital | The risk or severity of CNS depression can be increased when Butalbital is combined with Imagabalin. |
| Methysergide | The risk or severity of CNS depression can be increased when Methysergide is combined with Imagabalin. |
| Cabergoline | The risk or severity of CNS depression can be increased when Cabergoline is combined with Imagabalin. |
| Phenytoin | The risk or severity of CNS depression can be increased when Phenytoin is combined with Imagabalin. |
| Topiramate | The risk or severity of CNS depression can be increased when Topiramate is combined with Imagabalin. |
| Clemastine | The risk or severity of CNS depression can be increased when Clemastine is combined with Imagabalin. |
| Venlafaxine | The risk or severity of CNS depression can be increased when Venlafaxine is combined with Imagabalin. |
| Etomidate | The risk or severity of CNS depression can be increased when Etomidate is combined with Imagabalin. |
| Morphine | The risk or severity of CNS depression can be increased when Morphine is combined with Imagabalin. |
| Talbutal | The risk or severity of CNS depression can be increased when Talbutal is combined with Imagabalin. |
| Pentobarbital | The risk or severity of CNS depression can be increased when Pentobarbital is combined with Imagabalin. |
| Valproic acid | The risk or severity of CNS depression can be increased when Valproic acid is combined with Imagabalin. |
| Zolmitriptan | The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Imagabalin. |
| Codeine | The risk or severity of CNS depression can be increased when Codeine is combined with Imagabalin. |
| Dihydroergotamine | The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Imagabalin. |
| Tolcapone | The risk or severity of CNS depression can be increased when Tolcapone is combined with Imagabalin. |
| Hydromorphone | The risk or severity of CNS depression can be increased when Hydromorphone is combined with Imagabalin. |
| Olanzapine | The risk or severity of CNS depression can be increased when Olanzapine is combined with Imagabalin. |
| Cetirizine | The risk or severity of CNS depression can be increased when Cetirizine is combined with Imagabalin. |
| Protriptyline | The risk or severity of CNS depression can be increased when Protriptyline is combined with Imagabalin. |
| Trimethadione | The risk or severity of CNS depression can be increased when Trimethadione is combined with Imagabalin. |
| Clobazam | The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Imagabalin. |
| Chlorzoxazone | The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Imagabalin. |
| Clozapine | The risk or severity of CNS depression can be increased when Clozapine is combined with Imagabalin. |
| Meprobamate | The risk or severity of CNS depression can be increased when Meprobamate is combined with Imagabalin. |
| Thiethylperazine | The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Imagabalin. |
| Palonosetron | The risk or severity of CNS depression can be increased when Palonosetron is combined with Imagabalin. |
| Sulpiride | The risk or severity of CNS depression can be increased when Sulpiride is combined with Imagabalin. |
| Alprazolam | The risk or severity of CNS depression can be increased when Alprazolam is combined with Imagabalin. |